Literature DB >> 16807806

Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.

Catherine Clarke1, Jennifer Sandle, Sunil R Lakhani.   

Abstract

Until recently the myoepithelial cell has been studied relatively little in terms of its role in breast cancer. A number of malignancies showing myoepithelial differentiation have been reported in the literature, although they are still thought to be relatively rare and only limited studies are published. As a result of recent expression profiling experiments, one type of tumor with myoepithelial features, the so-called 'basal' breast cancer, has received a renewed interest, although it has been known to pathologists for more than two decades. These tumors, which express markers of both luminal and myoepithelial cells, are now being studied using antibodies against some new molecules that have emerged from studies of sorted normal luminal and myoepithelial cells. These immunohistochemical data, combined with genomic studies, may lead to better identification and management of patients with 'basal' tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16807806     DOI: 10.1007/s10911-005-9587-3

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  48 in total

Review 1.  14-3-3 proteins; bringing new definitions to scaffolding.

Authors:  G Tzivion; Y H Shen; J Zhu
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

2.  Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells.

Authors:  G L Prasad; E M Valverius; E McDuffie; H L Cooper
Journal:  Cell Growth Differ       Date:  1992-08

3.  Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells.

Authors:  K Joshi; J A Smith; N Perusinghe; P Monoghan
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

4.  Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

Authors:  C B Umbricht; E Evron; E Gabrielson; A Ferguson; J Marks; S Sukumar
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

5.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

Authors:  A T Ferguson; E Evron; C B Umbricht; T K Pandita; T A Chan; H Hermeking; J R Marks; A R Lambers; P A Futreal; M R Stampfer; S Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway.

Authors:  Tomoshige Kino; Emanuel Souvatzoglou; Massimo U De Martino; Maria Tsopanomihalu; Yihong Wan; George P Chrousos
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

7.  Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies.

Authors:  P Berthon; G Pancino; P de Cremoux; A Roseto; C Gespach; F Calvo
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

8.  Malignant myoepithelioma (myoepithelial carcinoma) of the breast: a detailed cytokeratin study.

Authors:  S R Lakhani; M J O'Hare; P Monaghan; J Winehouse; J C Gazet; J P Sloane
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

9.  CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

Authors:  C Jones; A V Nonni; L Fulford; S Merrett; R Chaggar; V Eusebi; S R Lakhani
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

10.  Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue.

Authors:  Peter T Simpson; Theodora Gale; Jorge S Reis-Filho; Chris Jones; Suzanne Parry; Dawn Steele; Antonio Cossu; Mario Budroni; Giuseppe Palmieri; Sunil R Lakhani
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

View more
  9 in total

Review 1.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

2.  Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line.

Authors:  B Dvořánková; P Szabo; L Lacina; O Kodet; E Matoušková; K Smetana
Journal:  Histochem Cell Biol       Date:  2012-01-24       Impact factor: 4.304

3.  A novel myoepithelial/progenitor cell marker in the breast?

Authors:  Zdenek Kolar; Jiri Ehrmann; Gulisa Turashvili; Jan Bouchal; Jaroslav Mokry
Journal:  Virchows Arch       Date:  2007-04-12       Impact factor: 4.064

Review 4.  [Anatomy of the breast].

Authors:  W Böcker; D Hungermann; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

5.  Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.

Authors:  Werner Boecker; Göran Stenman; Thomas Loening; Mattias K Andersson; Tobias Berg; Alina Lange; Agnes Bankfalvi; Vera Samoilova; Katharina Tiemann; Igor Buchwalow
Journal:  Virchows Arch       Date:  2014-10-26       Impact factor: 4.064

6.  Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.

Authors:  Sepi Mahooti; Kyle Porter; Mary L Alpaugh; Yin Ye; Yi Xiao; Susie Jones; Joseph D Tellez; Sanford H Barsky
Journal:  Oncotarget       Date:  2010-06

Review 7.  The Role of Extracellular Matrix Proteins in Breast Cancer.

Authors:  Arkadiusz Lepucki; Kinga Orlińska; Aleksandra Mielczarek-Palacz; Jacek Kabut; Pawel Olczyk; Katarzyna Komosińska-Vassev
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

8.  The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.

Authors:  Y L Chua; Y Ito; J C M Pole; S Newman; S-F Chin; R C Stein; I O Ellis; C Caldas; M J O'Hare; A Murrell; P A W Edwards
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

Review 9.  Role of myoepithelial cells in breast tumor progression.

Authors:  Puspa Raj Pandey; Jamila Saidou; Kounosuke Watabe
Journal:  Front Biosci (Landmark Ed)       Date:  2010-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.